Balaji  Gandhi net worth and biography

Balaji Gandhi Biography and Net Worth

CFO of Phreesia

As Chief Financial Officer, Balaji Gandhi leverages more than 25 years of executive experience to oversee the company’s budgeting, forecasting, monthly reporting, financial analysis, internal controls and investor relations.

Prior to joining Phreesia, he spent nearly a decade in leadership roles at companies including Madaket Health, Press Ganey and Fresenius Medical Care, where he worked across finance, corporate development, strategy and investor relations. He also spent more than a decade as an investment research analyst in the healthcare services market at several financial and investment firms, including Deutsche Bank, GE Capital and Oppenheimer & Co., Inc. Balaji holds a master’s degree in health services administration from The George Washington University and a BA from the University of Rochester.

What is Balaji Gandhi's net worth?

The estimated net worth of Balaji Gandhi is at least $2.68 million as of February 18th, 2025. Mr. Gandhi owns 105,514 shares of Phreesia stock worth more than $2,676,785 as of March 15th. This net worth estimate does not reflect any other investments that Mr. Gandhi may own. Learn More about Balaji Gandhi's net worth.

How old is Balaji Gandhi?

Mr. Gandhi is currently 50 years old. There are 6 older executives and no younger executives at Phreesia. The oldest executive at Phreesia is Ms. Janet M. Gunzburg, VP, Principal Accounting Officer & Controller, who is 58 years old. Learn More on Balaji Gandhi's age.

How do I contact Balaji Gandhi?

The corporate mailing address for Mr. Gandhi and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at investors@phreesia.com. Learn More on Balaji Gandhi's contact information.

Has Balaji Gandhi been buying or selling shares of Phreesia?

During the last ninety days, Balaji Gandhi has sold $1,435,101.68 of Phreesia stock. Most recently, Balaji Gandhi sold 5,771 shares of the business's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $30.04, for a transaction totalling $173,360.84. Following the completion of the sale, the chief financial officer now directly owns 105,514 shares of the company's stock, valued at $3,169,640.56. Learn More on Balaji Gandhi's trading history.

Who are Phreesia's active insiders?

Phreesia's insider roster includes Edward Cahill (Director), Balaji Gandhi (CFO), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Mark Smith (Director), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.

Are insiders buying or selling shares of Phreesia?

In the last twelve months, insiders at the sold shares 83 times. They sold a total of 378,140 shares worth more than $9,592,827.15. The most recent insider tranaction occured on February, 18th when COO Evan Roberts sold 3,519 shares worth more than $105,781.14. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.

Information on this page was last updated on 2/18/2025.

Balaji Gandhi Insider Trading History at Phreesia

See Full Table

Balaji Gandhi Buying and Selling Activity at Phreesia

This chart shows Balaji Gandhi's buying and selling at Phreesia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$1.44MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Phreesia Company Overview

Phreesia logo
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Read More

Today's Range

Now: $25.37
Low: $24.54
High: $25.87

50 Day Range

MA: $27.31
Low: $21.90
High: $29.99

2 Week Range

Now: $25.37
Low: $17.07
High: $30.53

Volume

804,595 shs

Average Volume

432,702 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03